News

The FDA is expected to make a decision whether to grant accelerated approval of Avastin for use in this most aggressive form of brain cancer by May 5,

This patent offers protection for the use of NB S101(strontium malonate) for the treatment of osteoporosis and related conditions while confirming that the innovative product, NB S101, demonstrated

As President and CEO, Mr Narachi will see through the completion of the remaining three Phase III trials for Contrave (naltrexone sustained release (SR)/bupropion SR) and its new

Of the $1.27 million contract, $1.13 million is Federal money provided by the NCI, and $146,088 is the contractor’s share provided by Intrinsic Bioprobes. This contract is in

ArunA Biomedical and Open Biosystems will launch the complete and fully validated induced pluripotent stem cell (viPS) kits containing all the tools and reagents necessary to generate patient

The company has granted the underwriter a 30-day option to purchase up to an additional 1.16 million shares to cover over-allotments, if any. UBS Investment Bank is the

James White, chief executive, osmetech plc, said: “We are delighted that Fisher HealthCare has partnered with Osmetech, highlighting the attraction of our eSensor XT-8 platform. Fisher HealthCare has

A member of the Institute of Medicine of the National Academy of Sciences and its committees on Human Embryonic Stem Cell Research and on Women’s Health Research, Adashi

Engineering and construction (E&C) sector material and equipment costs to decrease by end of 2009 or early next year, as per Fluor’s annual materials outlook study; copper, nickel